Susan Romanus
Geen lopende functies
Vermogen: 254 971 $ op 30-04-2024
Profiel
Susan Romanus worked as a Senior Director & Compliance Officer at Merck Vaccine Division.
She then worked as Vice President, Chief Ethics & Compliance Officer at Daiichi Sankyo Co., Ltd.
Later, she worked as Chief Compliance & Quality Officer at ADC Therapeutics SA. Finally, she worked as Vice President-Compliance at Taiho Oncology, Inc. Ms. Romanus completed her undergraduate degree from the University of California San Diego and her MBA from the University of San Diego.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ADC THERAPEUTICS LTD
0.07% | 01-02-2023 | 57 426 ( 0.07% ) | 254 971 $ | 30-04-2024 |
Eerdere bekende functies van Susan Romanus
Bedrijven | Functie | Einde |
---|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Compliance Officer | 01-01-2018 |
DAIICHI SANKYO CO., LTD. | Compliance Officer | 01-01-2012 |
Merck Vaccine Division | Compliance Officer | - |
ADC THERAPEUTICS SA | Compliance Officer | - |
Opleiding van Susan Romanus
University of California San Diego | Undergraduate Degree |
University of San Diego | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
DAIICHI SANKYO CO., LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Merck Vaccine Division |